Balchem Corporation stock page - price, fundamentals, dividends - iOCharts

BCPC

153.21
+0.39 (0.26%)
Balchem Corporation (NASDAQ, USD)
Basic Materials >
Specialty Chemicals
Market cap
4.97B
Ent value
5.20B
Price/Sales
7.06
Price/Book
5.85
Div yield
0.38%
Div growth
11.27%
Growth years
12
FCF payout
28.64%
Trailing P/E
58.72
Forward P/E
38.11
PEG
2.45
EPS growth
7.70%
1 year return
46.63%
3 year return
14.97%
5 year return
14.97%
10 year return
15.27%
Last updated: 2021-10-19

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open153.00
Daily high153.96
Daily low152.02
Daily Volume41K
All-time high153.21
1y analyst estimate141.75
Beta0.58
EPS (TTM)2.61
Dividend per share0.58
Ex-div date24 Dec 2020
Next earnings date27 Oct 2021

Downside potential

Loading...
Downside potential data
BCPCS&P500
Current price drop from All-time high-0.10%-2.36%
Highest price drop-67.48%-56.47%
Date of highest drop8 Apr 19999 Mar 2009
Avg drop from high-14.95%-11.45%
Avg time to new high19 days12 days
Max time to new high694 days1805 days

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share0.58
Dividend yield0.38%
Payout frequencyAnnual
Maximum yield0.72%
Average yield0.53%
Minimum yield0.38%
Discount to avg yield-39.05%
Upside potential-28.09%
Yield as % of max yield52.42%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield0.38%
Current yield distribution99.92%
Yield at 100% (Min)0.38%
Yield at 90%0.44%
Yield at 80%0.47%
Yield at 50% (Median)0.52%
Yield at 20%0.58%
Yield at 10%0.61%
Yield at 0% (Max)0.72%

Dividend per share

Loading...
Dividend per share data
Years of growth12 years
CCC statusDividend Contender
Dividend per share0.58
Payout frequencyAnnual
Ex-div date24 Dec 2020
EPS (TTM)2.61
EPS (1y forward)4.02
EPS growth (5y)7.70%
EPS growth (5y forward)24.00%

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
BCPCS&P500
DGR MR11.54%7.68%
DGR TTM11.54%-2.66%
DGR 3 years11.36%5.82%
DGR 5 years11.27%6.23%
DGR 10 years14.48%9.64%
DGR 15 years22.78%6.71%
Time since last change announced308 days
EPS growth (5y)7.70%
EPS growth (5y forward)24.00%

Payout ratio

Loading...
Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM39.48%28.64%
Average--
Forward14.43%-

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E58.72
Price to OCF33.02
Price to FCF42.60
Price to EBITDA31.51
EV to EBITDA32.98

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales7.06
Price to Book5.85
EV to Sales7.39

FINANCIALS

Per share

Loading...
Per share data
Current share count32.44M
EPS (TTM)2.61
FCF per share (TTM)3.60

Income statement

Loading...
Income statement data
Revenue (TTM)703.64M
Gross profit (TTM)223.90M
Operating income (TTM)111.15M
Net income (TTM)84.62M
EPS (TTM)2.61
EPS (1y forward)4.02

Margins

Loading...
Margins data
Gross margin (TTM)31.82%
Operating margin (TTM)15.80%
Profit margin (TTM)12.03%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash88.53M
Net receivables106.81M
Total current assets281.20M
Goodwill526.25M
Intangible assets113.66M
Property, plant and equipment235.22M
Total assets1.17B
Accounts payable138.35M
Short/Current long term debt162.27M
Total current liabilities88.76M
Total liabilities319.72M
Shareholder's equity849.49M
Net tangible assets849.49M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)150.49M
Capital expenditures (TTM)33.83M
Free cash flow (TTM)116.67M
Dividends paid (TTM)33.41M

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity10.22%
Return on Assets7.26%
Return on Invested Capital8.16%
Cash Return on Invested Capital11.25%
COMPANY DETAILS
BCPC (Balchem Corporation) company logo
Marketcap
4.97B
Marketcap category
Mid-cap
Description
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
Employees
1353
Investor relations
SEC filings
CEO
Theodore Harris
Country
USA
City
New Hampton
Stock type
Common stock
CCC status
Dividend Contender
Dividend Frequency
Annual
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
October 15, 2021
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company...
October 15, 2021
NEW HAMPTON, N.Y., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, October 29 at 11:00 AM Eastern Time (ET) to revie...
August 16, 2021
AzurRx expands Board of Directors to seven members with new appointmentBOCA RATON, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company ...
July 31, 2021
Thank you for joining our conference call this morning to discuss the results of Balchem Corporation for the quarter ending June 30, 2021. My name is Martin Bengtsson, Chief Financial Officer; and ho...
July 30, 2021
NEW HAMPTON, N.Y., July 30, 2021 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today record second quarter net earnings of $22.7 million for 2021, compared to net earnings of $21.1 m...
July 28, 2021
NEW HAMPTON, N.Y., July 28, 2021 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) Chairman of the Board, Chief Executive Officer, and President, Ted Harris and Chief Financial Officer, Martin Be...
July 19, 2021
To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...
July 16, 2021
NEW HAMPTON, N.Y., July 16, 2021 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, July 30 at 11:00 AM Eastern Time (ET) to review s...
June 13, 2021
Balchem's (NASDAQ:BCPC) stock up by 1.1% over the past three months. Given that the market rewards strong financials in...
May 18, 2021
NEW HAMPTON, N.Y., May 18, 2021 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) Chairman of the Board, Chief Executive Officer, and President Ted Harris and Chief Financial Officer Martin Bengt...
Next page